Illinois
Chicago; RUSH University
A Postmarketing Observational Study to Assess the Efficacy and Safety of Factor VIII/von Willebrand Factor Complex (Human), AlphanateŽ in Preventing Excessive Bleeding During Surgery in Subjects with Congenital Type 3 von Willebrand Disease
Kentucky
Lexington; University of Kentucky
A Postmarketing Observational Study to Assess the Efficacy and Safety of Factor VIII/von Willebrand Factor Complex (Human), AlphanateŽ in Preventing Excessive Bleeding During Surgery in Subjects with Congenital Type 3 von Willebrand Disease
Oklahoma City; University of Oklahoma
A Postmarketing Observational Study to Assess the Efficacy and Safety of Factor VIII/von Willebrand Factor Complex (Human), AlphanateŽ in Preventing Excessive Bleeding During Surgery in Subjects with Congenital Type 3 von Willebrand Disease
New York
New York; Mount Sinai Medical Center
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex (Humate-P, Antihemophilic Factor/Von Willebrand Factor Complex)
Ohio
Cincinnati; Cincinnati Children's Hospital Medical Center
A Postmarketing Observational Study to Assess the Efficacy and Safety of Factor VIII/von Willebrand Factor Complex (Human), AlphanateŽ in Preventing Excessive Bleeding During Surgery in Subjects with Congenital Type 3 von Willebrand Disease
Washington, DC
Washington; Lombardi Cancer Center
A Postmarketing Observational Study to Assess the Efficacy and Safety of Factor VIII/von Willebrand Factor Complex (Human), AlphanateŽ in Preventing Excessive Bleeding During Surgery in Subjects with Congenital Type 3 von Willebrand Disease
